Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Solv Announces New COVID-19 Vaccine Scheduling and Logistics Solution

Solv for Vaccines helps hospitals, clinics and government health organizations enable high volume logistics and vaccinate thousands of patients per day

Vaccination sites accelerate community access and vaccination delivery after moving operations from legacy technology to Solv


News provided by

Solv Health

Jan 28, 2021, 13:43 ET

Share this article

Share toX

Share this article

Share toX

SAN FRANCISCO, Jan. 28, 2021 /PRNewswire/ -- Solv, the leading digital healthcare platform for convenient care, today announced Solv for Vaccines, a scalable scheduling and logistics solution that enables hospitals, urgent care clinics and public health organizations to power high volume COVID-19 vaccination sites in every community across the country.

Continue Reading

New tech solution is accelerating vaccine delivery for hospitals, clinics, and government health organizations.

Post this
Solv for Vaccines Command Center
Solv for Vaccines Command Center

The world has embarked on one of the largest mass vaccination campaigns in human history. Accelerating vaccinations is critical to saving lives and reopening the country and economy, but the initial roll out has proven that quickly vaccinating millions of people is a tough logistical challenge for healthcare organizations and their partners in the public health community. Traditional healthcare technology and EMRs were not built to handle high volume vaccine scheduling or deliver clear and friendly patient experiences. Solv for Vaccines gives government officials and healthcare workers a solution that can easily flex to accommodate the surges in appointment volumes required to move through each phase of COVID-19 vaccine delivery. 

"Mass COVID-19 vaccination has presented government agencies and healthcare workers with the difficult challenge of scaling operations to treat thousands of patients each day. At Solv, we're seeing how the hard work and commitment of providers and public health officials paired with modern, simple and reliable technology can play a key role increasing the speed of vaccinations," said Heather Fernandez, CEO and Co-Founder of Solv. "Every day health departments, hospitals and clinics immediately overcome issues with their legacy scheduling technology when they quickly migrate to Solv's solution."

Built using Solv's on-demand scheduling platform, which has already booked over 5 million COVID-19 test appointments, Solv for Vaccines improves the end-to-end vaccination workflow--from patient eligibility pre-screening, to state immunization registry reporting. Delivered through a simple user experience, scheduling an appointment requires no logins, no downloads, and is accessible by all ages. Organizations migrating to Solv for Vaccines go-live in less than one week and can vaccinate thousands of patients per day at a single site.

"Vaccinating thousands of patients every day requires complex logistics and tight management of scheduling," said Kevin Brooks, COO of Swedish Health Services. "Switching our operation to Solv allowed us to dynamically match our vaccine capacity to the schedule, and communicate updates with patients. It's reducing no-shows and we deliver a great experience for patients."

Solv for Vaccines

Solv for Vaccines is easy-to-use for patients, regardless of their technical abilities. Patients can schedule and confirm an appointment online in less than a minute, without logging in or filling out long forms. With the Solv for Vaccines call center dashboard, organizations can easily schedule patients over the phone, extending their community reach. Solv's cloud-based solution is easy to configure and deploy quickly, so healthcare providers can get up and running in less than one week. Solv deploys new vaccination sites daily as more and more organizations discover the need to upgrade their logistics to meet the complex workflow and consumer demand for the COVID vaccine.

Solv for Vaccines includes:

  • Eligibility Pre-Screening - Prior to scheduling a vaccination, patients are prescreened for eligibility, reducing the administrative burden on clinical staff and allowing vaccination sites to manage their phased distribution approach.
  • Online Self-Scheduling - Eligible patients self select appointment times online, helping keep wait times short and optimizing the schedule.
  • Call Center Scheduling - The Solv call center dashboard improves equitable community access by allowing staff to schedule vaccinations over the phone, across multiple sites.
  • Reminders with Rescheduling - Text messages remind patients about their visit, and help reschedule or cancel the appointment online, if necessary. Reminders reduce no-shows and maximize appointment availability.
  • Paperless Registration - Customizable registration information is collected online. Digital paperwork with consent is available ahead of the visit, saving data entry time and increasing clinic efficiency.
  • Contactless Check-in - Patients use their mobile device to notify the clinic of their arrival and can wait remotely, in their car or outdoors, using the virtual waiting room.
  • Two Dose Scheduling - Second doses are quickly scheduled during the first visit, saving manual work for staff and automating reminders for the future appointment.
  • IIS Reporting - Immunization records are automatically available for reporting to the state's immunization registry saving time for your clinical team.

"Solv allowed us to stand-up a COVID vaccine scheduling tool in under a week, helping us give thousands of vaccines to our staff, patients, and community," said Elizabeth Brock, Application PM at Seattle Cancer Care Alliance."Even better, the real-time patient feedback we receive from Solv allows us to quickly adjust our vaccine workflows and improve the patient experience."

Solv's COVID-19 Response

Solv for Vaccines builds upon Solv's COVID testing solution, which has been used to schedule more than 5 million covid tests in 2020.  More 14 million visitors use the Solv app every month to get and stay connected to the healthcare they need. Thousands of hospital systems, government organizations, private practices, urgent care centers, private practices, and community pop-up sites have leveraged Solv technology to support their testing initiatives. This proven and scalable scheduling and patient experience technology is now helping partners launch COVID vaccination sites in less than a week. New sites are being deployed daily.

About Solv

Solv is a consumer healthcare app that connects you to a national network of convenient healthcare providers, helping you to simplify your everyday healthcare needs. Solv partners with high-quality care providers across the country to make convenient care simple, friendly and transparent, the way it should be. The services and appointments offered on Solv are powered by a network of convenient care providers who use Solv's patient experience software to deliver a modern and delightful doctor's visit. This software increases community access to healthcare by improving the quality of service and the performance of the practice. More than 25 million doctor's appointments and more than 5 million COVID tests have been booked using Solv.

SOURCE Solv Health

Related Links

http://www.solvhealth.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.